8-KRegulation FDExhibits & Filings

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (Dec 18, 2006)

Filed December 18, 2006For Securities:UNH

Summary

UnitedHealth Group Incorporated (UNH) filed an 8-K on December 18, 2006, primarily to announce its upcoming annual investor conference scheduled for December 19, 2006. This event is intended to provide institutional analysts and investors with updates and insights into the company's performance and strategy. While the filing itself is procedural, it is important for investors to note the context of ongoing investigations and potential restatements of financial statements, as highlighted in the press release attached as an exhibit. The company acknowledges significant risks and uncertainties, including the impact of the stock option investigation, related governmental reviews, potential litigation, and operational challenges such as rising healthcare costs and competition. Investors should pay close attention to the information presented at the investor conference for any new guidance or clarifications on these material issues.

Key Highlights

  • 1UnitedHealth Group announced its annual investor conference will be held on December 19, 2006, in New York City.
  • 2The conference is targeted at institutional analysts and investors.
  • 3The 8-K filing incorporates a press release (Exhibit 99.1) detailing the event.
  • 4The company explicitly acknowledges potential material impact from ongoing investigations into its stock option programs.
  • 5UnitedHealth Group warns that its financial statements from 1994 to 2005, and interim periods, may not be reliable due to these investigations, necessitating restatements.
  • 6Several governmental bodies (SEC, IRS, Senate Finance Committee, U.S. Attorney, Minnesota AG) are involved in reviews.
  • 7The company lists a broad range of risks, including increased healthcare costs, competition, and regulatory changes, that could affect future results.

Frequently Asked Questions

The primary purpose of this 8-K filing is to publicly announce that UnitedHealth Group will be hosting its annual investor conference on December 19, 2006, for institutional analysts and investors.

The company highlights ongoing investigations into its stock option programs, which have led to the determination that financial statements from 1994 to 2005 may require restatement. It also mentions related governmental reviews and potential litigation.

The company outlines several risks, including higher-than-anticipated healthcare costs, increased competition, uncertainties regarding Medicare and Medicaid funding, potential litigation and regulatory scrutiny, difficulties in information systems, and potential non-realization of benefits from acquisitions.

No, the company explicitly states that its financial statements for the years 1994 to 2005 and interim periods therein should not be relied upon due to the stock option investigation, and a restatement is anticipated.